Trial · NCT01127607
Adverse events80
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
61 to 80 of 80
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | socially withdrawn | Psychiatric disorders | Placebo Arm | 0 | 13 | 0 |
| other | socially withdrawn | Psychiatric disorders | Treatment Arm | 0 | 13 | 0 |
| other | socially withdrawn | Psychiatric disorders | All Participants in Period 1 Prescribed 30mg | 3 | 36 | 3 |
| other | socially withdrawn | Psychiatric disorders | All Participants in Period 1 Prescribed 50mg | 0 | 21 | 0 |
| other | socially withdrawn | Psychiatric disorders | All Participants in Period 1 Prescribed 70mg | 0 | 17 | 0 |
| other | motor tic | Nervous system disorders | Placebo Arm | 0 | 13 | 0 |
| other | motor tic | Nervous system disorders | Treatment Arm | 0 | 13 | 0 |
| other | motor tic | Nervous system disorders | All Participants in Period 1 Prescribed 30mg | 0 | 36 | 0 |
| other | motor tic | Nervous system disorders | All Participants in Period 1 Prescribed 50mg | 0 | 21 | 0 |
| other | motor tic | Nervous system disorders | All Participants in Period 1 Prescribed 70mg | 2 | 17 | 2 |
| serious | suicidal ideation | Psychiatric disorders | Placebo Arm | 0 | 13 | 0 |
| serious | suicidal ideation | Psychiatric disorders | Treatment Arm | 0 | 11 | 0 |
| serious | suicidal ideation | Psychiatric disorders | All Participants in Period 1 Prescribed 30mg | 0 | 36 | 0 |
| serious | suicidal ideation | Psychiatric disorders | All Participants in Period 1 Prescribed 50mg | 0 | 21 | 0 |
| serious | suicidal ideation | Psychiatric disorders | All Participants in Period 1 Prescribed 70mg | 0 | 17 | 0 |
| serious | self harm attempt | Psychiatric disorders | Placebo Arm | 0 | 13 | 0 |
| serious | self harm attempt | Psychiatric disorders | Treatment Arm | 0 | 11 | 0 |
| serious | self harm attempt | Psychiatric disorders | All Participants in Period 1 Prescribed 30mg | 0 | 36 | 0 |
| serious | self harm attempt | Psychiatric disorders | All Participants in Period 1 Prescribed 50mg | 0 | 21 | 0 |
| serious | self harm attempt | Psychiatric disorders | All Participants in Period 1 Prescribed 70mg | 0 | 17 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01127607/events?page=4